Skip to main content

Advertisement

Table 1 Patient demographics

From: Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study

  Control group (n = 28) CVVH group (n = 29) P value
Age 38 ± 18 27 ± 8 0.06
Percentage TBSA 58 ± 18 64 ± 18 0.21
Percentage full thickness 43 ± 27 49 ± 22 0.37
Inhalation injury 61% 41% 0.14
ISS 36 ± 14 35 ± 13 0.80
APACHE II# 36 ± 8 35 ± 5 0.76
MODS# 13 ± 4 12 ± 3 0.53
SOFA# 13 ± 4 13 ± 3 0.87
AKIN stage 3 71% 70% 0.84
BUN (mg/dl)* 58 ± 26 46 ± 24 0.07
Creatinine (mg/dl)* 2.8 ± 1 2.9 ± 2 0.88
Hospital day of T0 23 ± 26 17 ± 24 0.21
Septic shock 43% 42% 0.94
Shock (all cause) 68% 72% 0.50
ALI/ARDS 71% 55% 0.20
  1. All values calculated as means ± standard deviation. # Calculated at T0. * Measured on T0 – day of continuous renal replacement therapy initiation, diagnosis of renal failure or nephrology consultation.
  2. AKIN = acute kidney injury network; ALI = acute lung injury; APACHE = acute physiology and chronic health evaluation; ARDS = acute respiratory distress syndrome; BUN = blood urea nitrogen; CVVH = continuous venovenous hemofiltration; ISS = injury severity score; MODS = multiple organ dysfunction score; SOFA = sequential organ failure assessment; TBSA = total body surface area.